Summary
Proinsulin synthesis, insulin release and intracellular ATP concentrations were measured in isolated rat islets of Langerhans under control conditions of in vitro incubation and after treatment with several concentrations of streptozotocin for different periods of time. It was found that streptozotocin inhibited proinsulin synthesis, as well as insulin release, in a time and concentration dependent manner. The characteristics of the inhibition of these two processes were similar in general terms, but one dissimilarity was noted, i.e. after 60 min exposure to a high concentration of streptozotocin, proinsulin synthesis was inhibited more than insulin release. ATP content was reduced by high concentrations of streptozotocin, but it was found that proinsulin synthesis and insulin release could be inhibited without any effect on ATP content by a low (0.22 mM) concentration of streptozotocin. The effect of streptozotocin on proinsulin synthesis was judged to be the result of a target specificity for the B-cell rather than a specific effect on proinsulin relative to total protein synthesis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Herr, R.R., Eble, T.E., Bergy, M.E., Jahnke, H.K.: Isolation and characterization of streptozotocin. In: Antibiotics annual, pp. 236–240. New York: Antibiotica Inc. 1959–1960
Vavra, J.J., DeBoer, C., Dietz, A., Hanka, L.J., Sokolski, W.T.: Streptozotocin: a new antibacterial antibiotic. In: Antibiotics annual, pp. 230–235. New York: Antibiotica Inc. 1959–1960
Evans, J.S., Gerritsen, G.D., Mann, K.M., Owen, S.P.: Antitumor and hyperglycemic activity of streptozotocin (NSC 37917) and its cofactor, U 15 774. Cancer Chemother. Rep.48, 1–6 (1965)
Rakietene, N., Rakieten, M.L., Nadkarni, V.: Studies on the diabetogenic action of streptozotocin. Cancer Chemother. Rep.29, 91–98 (1963)
Herr, R.R., Jahnke, H.K., Argoudelis, A.D.: The structure of streptozotocin, J. Amer. chem. Soc.89, 4808–4809 (1967)
Junod, A., Lambert, A.E., Orci, L., Pictet, R., Gonet, A.E., Renold, A.E.: Studies on the diabetogenic action of streptozotocin. Proc. Soc. exp. Biol. (N.Y.)126, 201–205 (1967)
Junod, A., Lambert, A.E., Stauffacher, W., Renold, A.E.: Diabetogenic action of streptozotocin: Relationship of dose to metabolic response. J. clin. Invest.48, 2129–2139 (1969)
Brosky, G., Logothetopoulos, J.: Streptozotocin diabetes in the mouse and guinea pig. Diabetes18, 606–611 (1969)
Pitkin, R.M., Reynolds, W.A.: Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes19, 85–90 (1970)
Schein, P.S., Alberti, K.G.M. M., Williamson, D. H.: Effects of streptozotocin on carbohydrate and lipid metabolism in the rat. Endocrinology89, 827–934 (1971)
Sybulski, S., Maughan, G.B.: Use of streptozotocin as diabetic agent in pregnant rats. Endocrinology89, 1537–1540 (1971)
Lazarus, S.S., Shapiro, S.H.: Streptozotocin-induced diabetes and islet cell alterations in rabbits. Diabetes21, 129–137 (1972)
Dixit, P.K., Tam, B.B., Hernandez, R.E.: Comparison of the effect of diabetogenic agents on the microdissected pancreatic islet tissue of the rat. Proc. Soc. exp. Biol. (N.Y.)140, 1418–1423 (1972)
Zapf, J., Waldvogel, M., Froesch, E.R.: Protein kinase and cyclic-AMP binding activities in liver and adipose tissue of normal, streptozotocin-diabetic and adrenalectomized rats. FEBS Letters36, 253–256 (1973)
Reaven, E.P., Reaven, G.M.: Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rats. J. clin. Invest.54, 1167–1178 (1974)
Renold, A.E., Rabinovitch, A., Wollheim, C., Kikuchi, M., Gutzeit, A., Amherdt, M., Malaisse-Lagae, F., Orci, L.: Spontaneous and experimental diabetic syndromes in animals. A re-evaluation of their usefulness for approaching the physiopathology of diabetes. Excerpta Medica International Congress Series312, pp. 22–38. Amsterdam 1974
Schein, P.S., Cooney, D.A., Vernon, M.L.: The use of nicotinamide to modify the toxicity of streptozotocin diabetes without loss of antitumoral activity. Cancer Res.27, 2324–2332 (1967)
Schein, P.S., Loftus, S.: Streptozotocin: Depression of mouse liver pyridine nucleotides. Cancer Res.28, 1501–1506 (1968)
Dulin, W.E., Wyse, B.M.: Studies on the ability of compounds to block the diabetogenic activity of streptozotocin. Diabetes18, 459–466 (1969)
Stauffacher, W., Burr, I., Gutzeit, A., Beaven, D., Veleminsky, J., Renold, A.E.: Streptozotocin diabetes: Time course of irreversible B-cell damage; further observations on prevention by nicotinamide. Proc. Soc. exp. Biol. (N.Y.)133, 194–200 (1970)
Stauffacher, W., Balant, L., Amherdt, D.P., Cameron, L., Orci, L.: Mode of action of streptozotocin: indication for accelerated NAD destruction. Diabetologia8, (Abstr.) 68 (1972)
Chang, A.Y.: On the mechanism for the depression of liver NAD by streptozotocin. Biochem. biophys. Acta (Amst.)261, 77–84 (1972)
Lazarus, S.S., Shapiro, S.H.: Influence of nicotinamide and pyridine nucleotides on streptozotocin and alloxan-induced pancreatic B-cell cytotoxicity. Diabetes22, 499–506 (1973)
Gunnarson, R., Berne, C., Hellerstrom, G.: Cytotoxic effects of streptozotocin and N-nitrosomethylurea on the pancreatic B-cells, with special regard to the role of nicotinamide adenine dinucleotide. Biochem. J.140, 487–494 (1974)
Anderson, T., Schein, P.S., McMenamin, M.G., Cooney, D. A.: Streptozotocin diabetes: Correlation with extent of depression of pancreatic islet nicotinamide adenine dinucleotide. J. clin. Invest.54, 672–677 (1974)
Rakieten, N., Gordon, B.S., Beaty, A., Cooney, D.A., Davis, R.D., Schein, P. S.: Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc. Soc. exp. Biol. (N. Y.)137, 280–283 (1971)
Volk, B.W., Wellmann, K.F., Brancato, P.: Fine structure of rat islet cell tumors induced by streptozotocin and nicotinamide. Diabetologia10, 37–44 (1973)
Wyse, B.M., Dulin, W.E.: The effects of streptozotocin on glucose oxidation by isolated islets of Langerhans. Proc. Soc. exp. Biol. (N.Y.)136, 70–72 (1971)
Golden, P., Baird, L., Malaisse, W.J., Malaisse-Lagae, F.: Effect of streptozotocin on glucose-induced insulin secretion by isolated islets of Langerhans. Diabetes20, 513–518 (1971)
Taylor, K.W.: Regulation of insulin synthesis: International Congress of Endocrinology III, pp. 220–224. (1968)
Lacy, P.E., Kostianovsky, M.: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes16, 35–39 (1967)
Eagle, H.: Amino-acid metabolism in mammalian cell cultures. Science130, 432–437 (1959)
Davoren, P.R.: The isolation of insulin from a single cat pancreas. Biochim. biophys. acta (Amst.)63, 150–153 (1962)
Permutt, M.A., Kipnis, D.M.: Insulin biosynthesis. On the mechanism of glucose stimulation. J. biol. Chem.247, 1194–1199 (1972)
Pipeleers, D.G., Marichal, M., Malaisse, W.J.: The stimulus-secretion coupling of glucose-induced insulin release. XIV. Glucose regulation of insular biosynthetic activity. Endocrinology93, 1001–1011 (1973)
Herbert, V., Lau, K.S., Gottlieb, C.W., Bleicher, S.J.: Coated charcoal immunoassay of insulin. J. clin. Endocr.25, 1375–1384 (1965)
Greenwood, F.C., Hunter, W.M., Glover, J.S.: The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem. J.89, 114–123 (1963)
Strehler, B.L., Totter, J.R.: Determination of ATP and related compounds: Firefly luminescence and other methods. In: Methods of biochemical analysis, Vol. 1, (ed. D. Glick), p. 341. New York: Interscience
Wettermark, G., Tegnér, L., Brolin, S.E., Borglund, E.: Photokinetic measurements of the ATP and ADP levels in isolated islets of Langerhans. In: The structure and metabolism of the pancreatic islets, Werner-Gren Symposium N. 16. (eds. G. Falkner, B. Hellman, I.B. Täljedal). Oxford: Pergamon Press 1970
Ashcroft, S.J. H., Weerasinghe, L.C.C. Randle, P.J.: Interrelationship of islet metabolism, adenosine triphosphate content and insulin release. Biochem. J.132, 223–231 (1973)
Hellman, B.: The relation between age and the B/A cell ratio in the islet tissue of the rat. Acta endocr. (Kbh.)31, 80–90 (1959)
Hellman, B.: The effect of ageing on the total volumes of the A and B cells in the islets of Langerhans of the rat. Acta endocr. (Kbh.)32, 92–112 (1959)
Karunanayake, E.H., Hearse, D.J., Mellows, G.: The synthesis of (14C)-streptozotocin and its distribution and excretion in the rat. Biochem. J.142, 673–683 (1974)
Sando, H., Borg, J., Steiner, D.F.: Studies on the secretion of newly synthesized proinsulin and insulin from isolated rat islets of Langerhans. J. clin. Invest.51, 1476–1485 (1972)
Author information
Authors and Affiliations
Additional information
This work was supported by the Swiss National Scientific Foundation (Grant No. 3106073), Berne, Switzerland, and by a grant-in-aid from Hoechst Pharmaceuticals, Frankfurt-Hoechst, Germany
Rights and permissions
About this article
Cite this article
Maldonato, A., Trueheart, P.A., Renold, A.E. et al. Effects of streptozotocin in vitro on proinsulin biosynthesis, insulin release and ATP content of isolated rat islets of Langerhans. Diabetologia 12, 471–481 (1976). https://doi.org/10.1007/BF01219511
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01219511